Author details

Full Name

Elena S Izmailova

Affiliation

ORCID

Career Start Year

1999

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37118983	Digital health technology derived measures: BiomarkersÂ or clinical outcome assessments?		2023
36382716	Empowering drug development: Leveraging insights from imaging technologies to enable the advancement of digitalÂ health technologies.	Clinical and Translational Science	2023
37157935	Digital technologies: Innovations that transform the face of drug development.		2023
37206894	Reverse Engineering of Digital Measures: Inviting Patients to the Conversation.	Digit Biomark	2023
34796676	Response to "Wearable Remote Monitoring and COVID-19".	Clinical and Translational Science	2022
36162013	When Work Hits Home: The Cancer-Treatment Journey of a Clinical Scientist Driving Digital Medicine.	JCO clinical cancer informatics	2022
36016036	Sensor Verification and Analytical Validation of Algorithms to Measure Gait and Balance and Pronation/Supination in Healthy Volunteers.	Sensors	2022
35949223	Considerations for Conducting Bring Your Own "Device" (BYOD) Clinical Studies.	Digit Biomark	2022
35436221	Recommendations for Defining and Reporting Adherence Measured by Biometric Monitoring Technologies: Systematic Review.	Journal of Medical Internet Research	2022
34446278	Multimodal biometric monitoring technologies drive the development of clinical assessments in the home environment.		2021
34179682	EVIDENCE Publication Checklist for Studies Evaluating Connected Sensor Technologies: Explanation and Elaboration.	Digital Biomarkers	2021
34080295	Closer to the patient means better decisions: wearable remote monitoring of patients with COVID-19 lung disease.	Clinical and Translational Science	2021
34236887	Biometric Monitoring Technologies in Cancer: The Past, Present, and Future.	JCO clinical cancer informatics	2021
34056520	Remote Cardiac Safety Monitoring through the Lens of the FDA Biomarker Qualification Evidentiary Criteria Framework: A Case Study Analysis.	Digit Biomark	2021
33048470	Remote FEV1 Monitoring in Asthma Patients: A Pilot Study.	Clinical and Translational Science	2021
32770726	Fit-for-Purpose Biometric Monitoring Technologies: Leveraging the Laboratory Biomarker Experience.	Clinical and Translational Science	2021
32866314	An Evaluation of Biometric Monitoring Technologies for Vital Signs in the Era of COVID-19.	Clinical and Translational Science	2020
31955410	In-House Data on the Outside-A Mobile Health Approach.	Clinical Pharmacology and Therapeutics	2020
32409759	Remote digital monitoring in clinical trials in the time of COVID-19.	Nat Rev Drug Discov	2020
32337371	Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs).	NPJ Digit Med	2020
32526077	Remote Monitoring in Clinical Trials During the COVID-19 Pandemic.	Clinical and Translational Science	2020
31365190	Continuous Monitoring Using a Wearable Device Detects Activity-Induced Heart Rate Changes After Administration of Amphetamine.	Clinical and Translational Science	2019
30635980	Evaluation of Wearable Digital Devices in a Phase I Clinical Trial.	Clinical and Translational Science	2019
29205294	Wearable Devices in Clinical Trials: Hype and Hypothesis.	Clinical Pharmacology and Therapeutics	2018
22515704	Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines.	Mol Cancer	2012
21345816	Monocyte migration to the synovium in rheumatoid arthritis patients treated with adalimumab.	Annals of the Rheumatic Diseases	2011
21305505	Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factor.	Arthritis Rheum	2011
19924229	Monocyte scintigraphy in rheumatoid arthritis: the dynamics of monocyte migration in immune-mediated inflammatory disease.	PLoS ONE	2009
19287509	Genome-wide association study of determinants of anti-cyclic citrullinated peptide antibody titer in adults with rheumatoid arthritis.	Mol Med	2009
18567923	Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells.	Brain	2008
17666451	Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study.	Ann Rheum Dis	2008
17195214	Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis.		2007
17612897	Quantitation of peripheral blood markers of rat experimental autoimmune encephalomyelitis.	Autoimmunity	2007
17696278	Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate.	J Rheumatol	2007
17982456	Two independent alleles at 6q23 associated with risk of rheumatoid arthritis.	Nat Genet	2007
16849501	PKC-theta-deficient mice are protected from Th1-dependent antigen-induced arthritis.	Journal of Immunology	2006
14712222	Stat3 enhances vimentin gene expression by binding to the antisilencer element and interacting with the repressor protein, ZBP-89.	Oncogene	2004
12743285	The simian immunodeficiency virus 5' untranslated leader sequence plays a role in intracellular viral protein accumulation and in RNA packaging.	Journal of Virology	2003
12539042	HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages.	Nature Medicine	2003
11932430	Functional analysis of the murine sarcoma virus RNA packaging sequence.	Journal of Virology	2002
10670648	A Stat1alpha factor regulates the expression of the human vimentin gene by IFN-gamma.	Journal of Interferon and Cytokine Research	2000
10196480	An antisilencer element is involved in the transcriptional regulation of the human vimentin gene.	Gene	1999
10415334	A GC-box is required for expression of the human vimentin gene.	Gene	1999